Latest Updates
-
Hustle Culture Has a Bedroom Problem No One Talks About, Expert Explains -
Iris Young Minds Initiative: How A Noida CSR Programme Is Opening Up Talk On Student Stress -
Lal Hit Janta Party Explained: Who Is Behind The Rival to the Cockroach Janta Party -
Barbara Palvin In Victoria’s Secret Fashion Show Six Weeks After Birth -
Maha Navami Significance: Why The Ninth Day Of Navratri Matters Most -
Festive FOMO Is Changing Dating Habits, Survey Finds Nearly Half Of Singles Are Delaying Matches -
Tiger Shroff Firing Incident: What Happened In Mumbai's Juhu? Latest Updates -
Eat, Celebrate, Repeat: 6 Ayurvedic Tips To Keep Your Digestion Happy This Navratri 2026 -
Breast Cancer Awareness Month 2026: Expert Explains The Emotional Toll Of Breast Cancer -
Navratri 2026 Food Hopping In Delhi NCR: 7 Places To Explore For A Taste Of Festive Flavours
Now, Multicolour MRIs To Improve Disease Detection
Read to know about multicolour MRIs to improve disease detection.
Scientists have developed a new method to make magnetic resonance imaging (MRI) multicolour to improve disease detection. Current MRI techniques rely on a single contrast agent injected into a patient's veins to vivify images. The new method uses two agents at once, which could allow doctors to map multiple characteristics of a patient's internal organs in a single MRI.

"The method we developed enables, for the first time, the simultaneous detection of two different MRI contrast agents," said Chris Flask, associate professor at Case Western Reserve University School of Medicine in the US. Two contrast agents could include one specifically targeting diseased tissue, and one designed to show healthy tissue, for example.
The new method would enable immediate comparisons of how each agent distributes in the same patient. "This multi-agent detection capability has the potential to transform molecular imaging, as it provides a critical translational pathway for studies in patients," said Flask. "It also provides a unique imaging platform to rigorously study molecular therapies," he said.
Therapies could include those targeting biomarkers or other detectable molecules associated with diseases. Two contrast agents, gadolinium and manganese, can be detected and independently quantified during MRIs, researchers said.

The results provide "an adaptable, quantitative imaging framework to assess two MRI contrast agents simultaneously for a wide variety of imaging applications," they said. The researchers have begun to investigate widespread practical applications for the new MRI approach.
"We validated our new methodology, opening the possibility for numerous follow-on application studies in cancer, genetic diseases such as cystic fibrosis, and metabolic diseases such as diabetes," Flask added. The research was published in the journal Scientific Reports.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
